Oxazolidinones represent a novel class of antibiotics that inhibit protein synthesis in sensitive bacteria. The mechanism of action and location of the binding site of these drugs is not clear. A new representative of oxazolidinone antibiotics, linezolid, was found to be active against bacteria and against the halophilic archaeon Halobacterium halobium. The use of H. halobium, which possess only one chromosomal copy of rRNA operon, allowed isolation of a number of linezolid-resistance mutations in rRNA. Four types of linezolid-resistant mutants were isolated by direct plating of H. halobium cells on agar medium containing antibiotic. In addition, three more linezolid-resistant mutants were identi®ed among the previously isolated mutants of H. halobium containing mutations in either 16 S or 23 S rRNA genes. All the isolated mutants were found to contain single-point mutations in 23 S rRNA. Seven mutations affecting six different positions in the central loop of domain V of 23 S rRNA were found to confer resistance to linezolid. Domain V of 23 S rRNA is known to be a component of the ribosomal peptidyl transferase center. Clustering of linezolid-resistance mutations within this region strongly suggests that the binding site of the drug is located in the immediate vicinity of the peptidyl transferase center. However, the antibiotic failed to inhibit peptidyl transferase activity of the H. halobium ribosome, supporting the previous conclusion that linezolid inhibits translation at a step different from the catalysis of the peptide bond formation.
Introduction
Oxazolidinones are a novel class of synthetic antibiotics highly active against Gram-positive organisms (Slee et al., 1987; Brickner et al., 1996) . These drugs inhibit protein synthesis, both in vivo and in vitro (Eustice et al., 1988; Shinabarger et al., 1997) . Importantly, they do not show cross-resistance with other known inhibitors of translation. The mechanism of oxazolidinone action remains elusive and the precise step in protein synthesis that is affected by the drugs is not clear. Binding studies showed that oxazolidinones interact primarily with the large ribosomal subunit . This conclusion was corroborated by isolation of two resistance mutations in 23 S rRNA of Staphylococcus aureus (Swaney et al., 1998b) . Binding of oxazolidinones to the large ribosomal subunit was inhibited by chloramphenicol, lincomycin and clindamycin, drugs known to interact with the ribosomal peptidyl transferase center . Some evidence indicated that oxazolidinones may inhibit protein synthesis at the initiation phase of translation (Eustice et al., 1988; Shinabarger et al., 1997; Burghardt et al., 1998) ; however, there remains controversy regarding the step of initiation that may be inhibited by the drug (Burghardt et al., 1998; Swaney et al., 1998a) .
Most of the ribosome-targeted antibiotics interact directly with rRNA (Allen & Noller, 1991; Fourmy et al., 1998; Douthwaite, 1992; Egebjerg et al., 1989; Mankin, 1997) . Identifying positions in rRNA that are involved in interactions with a drug reveals the location of the drug binding site and may provide insights into the mechanism of drug action. One of the most useful techniques for mapping rRNA residues involved in drug binding is characterization of drug-resistant mutations. The halophilic archaeon Halobacterium halobium, which contains only one copy of the rRNA operon in its genome (Hofman et al., 1979; Mankin & Kagramanova, 1986) , has been one of the most successfully used models for studying rRNA mutations. In contrast to the vast majority of organisms containing multiple copies of rRNA operons, a mutation in a single-copy rRNA gene of H. halobium results in production of a homogeneous population of mutant ribosomes in the cell. A number of H. halobium mutants resistant to different inhibitors of translation have been isolated, providing useful information about the nature and location of the drug binding sites and mechanisms of drug action (Hummel & Bo È ck, 1987a,b; Mankin & Garrett, 1991; Leviev et al., 1994; Tan et al., 1996; Mankin, 1997; Porse & Garrett, 1999) . Here, we describe isolation of a number of oxazolidinone-resistant H. halobium mutants. Clustering of the resistance mutations within the central loop of domain V is consistent with the oxazolidinone primary binding site being located within the ribosomal peptidyl transferase center.
Results

Isolation of linezolid-resistant mutants
Linezolid (Lin) is a new antibiotic of the oxazolidinone type (Figure 1 ). It is highly active against Gram-positive bacteria and inhibits protein synthesis by interacting with bacterial ribosomes . We found that the halophilic archaeon H. halobium is also highly sensitive to the drug. The growth of H. halobium culture was signi®cantly inhibited by 1 mM Lin and completely abolished by 3 mM Lin. Assuming that the mechanism of drug action is the same in different organisms, this ®nd-ing suggests that Lin interacts with a highly conserved site in the ribosome that has not undergone signi®cant changes since separation of the archaeal and bacterial evolutionary branches. Therefore, we used H. halobium as a model system for isolation of Lin r mutations in rRNA in order to characterize the site of binding and action of oxazolidinones.
For isolation of Lin r mutants, 10 9 H. halobium cells were plated onto agar medium containing 15 mM Lin. After two weeks incubation, about 100 resistant colonies appeared on the plate and 21 randomly picked colonies were chosen for mutation mapping. Sequencing of the complete 23 S rRNA gene from one of the isolates revealed the presence of a single mutation, C2452U in domain V (here and in the rest of the text, Escherichia coli numeration of 23 S rRNA is used). Therefore, with the other 20 isolates, the sequencing effort was focused on domain V of 23 S rRNA. The segment of the rRNA operon corresponding to domain V of 23 S rRNA was ampli®ed directly from the Lin r H. halobium colonies and the resulting PCR products were sequenced without additional cloning.
All of the 21 analyzed clones contained mutations in domain V of 23 S rRNA. Twelve clones had the C2452U mutation, ®ve clones had the U2500C mutation, three clones had the A2453G mutation and one clone had the U2504C mutation (Figure 2 ). Amongst the selected mutations, the U2500C conferred the highest Lin resistance. The minimal inhibitory concentration (MIC) of Lin for the U2500C mutant in the liquid culture was higher than 0.2 mM (the highest drug concentration tested). Other selected mutants also conferred resistance to high concentrations of Lin. MIC of Lin for the U2504C, C2452U and A2453G mutants was 180 mM, 160 mM and 130 mM, respectively (Table 1) .
Introduction of C2452U mutation into wild-type cells
A single-point mutation (C2452U) was found in the fully sequenced 23 S rRNA gene from one of the Lin r clones and only single mutations were found in domain V of 23 S rRNA in each of the other 20 analyzed clones. The frequency with which mutants appeared on the selection plate corresponded to the frequency of appearance of single-point mutations in H. halobium rRNA (10 À7 -10 À8 ) (Hummel & Bo È ck, 1987a,b; Mankin, 1997) . The frequency of a double mutation (10 À14 -10
À16
) is so low that it would be highly unlikely that any of the mutants studied would have another mutation outside of domain V in 23 S rRNA. Therefore, we tentatively concluded that in all the isolated mutants Lin resistance was conferred by individual point mutations in domain V. This conclusion was experimentally veri®ed for one of the isolated mutants, C2452U. The C2452U mutation was introduced into the single chromosomal rRNA operon of wild-type H. halobium using a previously developed transformation-recombination system which utilizes a suicidal vector pHRZH. The pHRZH vector contains the complete H. halobium rRNA operon with two selectable thiostrepton (Ths)-resistance mutations in the 23 S rRNA gene (A1067G and A1095G) combined with the C2452U mutation in the same gene (Mankin et al., 1992; Mankin, 1995) . pHRZH is unstable in H. halobium cells, either in the free or in the chromosome-integrated form, and can confer Ths-resistance to the transformed cells only by homologous replacement of a segment of the wild-type chromosomal 23 S rRNA gene with the segment from the vector-borne 23 S rRNA gene. Wild-type H. halobium cells were transformed with pHRZH and transformants were selected on a plate containing Ths. A number of transformants containing two Ths r mutations (A1067G and A1095G) were identi®ed by direct sequencing of the PCR-ampli®ed corresponding region of 23 S rRNA and amongst those transformants, a clone that contained the C2452U mutation, transferred to the chromosomal 23 S rRNA gene together with Ths r mutations, was found. Lin resistance exhibited by this clone was indistinguishable from that of the originally selected C2452U mutant (Figure 3 ), whereas a clone containing two Ths r mutations without C2452U mutation remained as sensitive to Lin as the wild-type. Since transformed cells were never exposed to Lin during selection of the transformants, appearance of the second-site mutations contributing to Lin resistance was highly unlikely. Therefore, we concluded that the presence of the C2452U transition in domain V of 23 S rRNA was suf®cient to produce the Lin r phenotype. Taking into account a similar frequency of appearance of various Lin r mutants, the results of the transformation experiment, therefore, supported our conclusion that resistance in all the selected mutants is determined by a single-point mutation in 23 S rRNA.
Testing Lin resistance of the previously selected H. halobium mutants containing mutations in rRNA genes
Our screening for Lin r mutants was not exhaustive. Therefore, we tested Lin sensitivity of a number of H. halobium mutants with mutations in 23 S or 16 S rRNA that were previously selected for their resistance to different protein synthesis inhibitors (Mankin & Garrett, 1991; Leviev et al., 1994; Tan et al., 1996; Mankin, 1997; Hummel & Bo È ck, 1987a) . The results of these tests are presented in Table 1 and Figure 3 . Three of the tested mutants that contained mutations in 23 S rRNA conferring chloramphenicol-resistance (A2062C), sparsomycinresistance (C2499U) and anisomycin-resistance-A2453C, exhibited resistance to Lin. However, the level of Lin-resistance conferred by these mutations was lower than that conferred by the directly selected Lin r mutants (Table 1 ). The other two 
Footprinting Lin on the H. halobium ribosome
The isolated mutations indicated that the Lin binding site is located in domain V of 23 S rRNA. We attempted to further de®ne the Lin binding site on the ribosome using RNA footprinting. H. halobium wild-type ribosomes were incubated with 2 mM Lin and rRNA bases were probed using dimethyl sulfate, kethoxal and carbodiimide. We did not observe any change in rRNA accessibility to chemical modi®cation, despite the very high concentration of Lin used in these experiments.
Testing effect of Lin on the peptidyl transferase reaction
The mutation analysis revealed that the Lin binding site involves the central loop of domain V of 23 S rRNA, which is known to be an integral part of the ribosomal peptidyl transferase center. This prompted us to examine the effect of Lin on the peptidyl transferase activity of H. halobium ribosomes. The peptidyl transferase assay was performed in the``fragment reaction'' conditions (in the presence of 33 % methanol) (Monro & Marcker, 1967) , using formyl-methionyl-tRNA as a donor substrate and puromycin as an acceptor (Tan et al., 1996) . As Figure 4 shows, Lin had no effect on the extent of the reaction, whereas the known inhibitor of the peptidyl transferase reaction, carbomycin, ef®ciently inhibited the peptidyl transferase activity of the H. halobium ribosome. Thus, Lin inhibits translation at a step different from the catalysis of peptide bond formation.
Discussion
Oxazolidinone binding site and mechanism of action The site of binding and mechanism of action of oxazolidinones remain a matter of controversy. On one hand, binding studies and competition experiments suggested interaction of oxazolidinones with the large ribosomal subunit . On the other hand, oxazolidinones were proposed to inhibit binding of mRNA to the small ribosomal subunit (Eustice et al., 1988) , and they were shown to interfere with formation of the 30 S initiation complex (Swaney et al., 1998a), implying possible Mankin & Garrett (1991) , Tan et al. (1996) and unpublished results. Abbreviations: Pri I, pristinamycin I; Cam, chloramphenicol; Ans, anisomycin; Spm, sparsomycin.
d The average of two independent experiments. e The data regarding doubling time of the C2499U mutant were taken from (Tan et al., 1996) . f 200 mM was the highest concentration of linezolid tested in these experiments. interaction of the drug with the small subunit. Furthermore, crosslinking of oxazolidinones to rRNA of the large and small ribosomal subunits was reported recently (Matassova et al., 1999) .
Here, we present the results of mutational analysis that we used to delineate the site of oxazolidinone action on the ribosome. All of the 21 randomly picked Lin r mutants contained mutations in rRNA. Seven mutations that confer resistance to linezolid, an oxazolidinone, were characterized in rRNA. The frequency of appearance of resistant mutants (10 À7 -10 À8 ) corresponded to the frequency of occurrence of single-point mutations in the H. halobium genome, thus strongly suggesting that no second site mutations (for example, in ribosomal protein genes) contributed to the resistance (Hummel & Bo È ck, 1987a,b; Mankin, 1995) . This conclusion was further con®rmed when one of the isolated mutations, C2452U, was introduced into the chromosome of wild-type cells; the engineered mutant was resistant to Lin. The fact that all Lin r mutations were con®ned to rRNA argues that interaction with rRNA is critical for Lin binding and/or action.
In spite of the existence of numerous rRNA mutations conferring oxazolidinone-resistance, RNA footprinting did not reveal any change in accessibility of rRNA bases to chemical modi®-cation in the presence of linezolid. This, however, is not that surprising, since none of the four nucleotides whose mutation confer high resistance to linezolid (C2452, A2453, U2500 and U2504) is accessible to chemical modi®cation in the H. halobium ribosome, thus making it impossible to detect interaction of the drug with these RNA bases using the footprinting technique. In addition, reagents used for RNA footprinting probe only certain positions in RNA bases; therefore, not every interaction of an RNA base with a ligand can be detected using this method. Indeed, there are welldocumented examples of antibiotics that interact with rRNA without changing the accessibility of nucleotides to chemical modi®cation (Tan et al., 1996; La Âzaro et al., 1996 , Porse et al., 1999a .
Though our results clearly point to the importance of rRNA for oxazolidinone binding and/or action, they do not exclude involvement of ribosomal proteins. Theoretically, oxazolidinones may bind to a ribosomal protein and the mutations in rRNA can alter protein conformation or its interactions with rRNA. This scenario, however, seems unlikely for a number of reasons. First, if ribosomal proteins were directly involved in binding or action of the drug, one would expect that resistance mutations will arise with high frequency in rRNA and in ribosomal protein gene(s), as was shown for another ribosome-targeted antibiotic, thiostrepton (Porse et al., 1998) . However, all of the characterized Lin r mutants of H. halobium contained mutations in rRNA rather than in ribosomal protein genes. Second, it is hard to imagine that several (seven!) different rRNA mutations will affect conformation of a ribosomal protein in the same way as to inhibit drug binding. This would be possible if rRNA mutations cause protein dissociation; however, gel electrophoresis analysis showed that mutant ribosomes had the same protein composition as the wild-type ribosomes (data not shown). Therefore, we favor the hypothesis that rRNA plays the major role in interaction of oxazolidinones with the ribosome.
All the Lin r mutations were localized in the central loop of domain V of 23 S rRNA, suggesting that this rRNA segment constitutes a critical component of the Lin binding site on the ribosome. The central loop of domain V, and neighboring rRNA segments, play a crucial role in ribosomal functions related to polypeptide synthesis. Compelling evidence implicate this rRNA region in interaction with the 3 H end of aminoacyl-tRNA and peptidyl-tRNA, and in the organization of the peptidyl transferase center (for recent reviews, see Wower et al., 1995; Green & Noller, 1997) . A number of ribosome-targeted antibiotics, in particular those that inhibit the function of the peptidyl transferase center, interact with this, arguably, the most functionally important segment of rRNA (for reviews, see Douthwaite, 1992; ; for more recent results, see Tan et al., 1996; La Âzaro et al., 1996; Porse & Garrett, 1999; Porse et al., 1999a,b) . Lin was shown to compete with two peptidyl transferase inhibitors, chloramphenicol and lincomycin, for binding to the ribosome Figure 4 . The lack of inhibition of the peptidyl transferase reaction by linezolid. The peptidyl transferase assay was performed under the``fragment reaction'' conditions as described in Materials and Methods. No puromycin was added to the control reaction (``control''). The reaction product, [H 3 ]formyl-methionylpuromycin was extracted into ethyl acetate phase and counted in the scintillation counter.
Oxazolidinone Resistance Mutations in 23 S rRNA . In addition, some of the Lin r mutations described here (Figure 3) confer chloramphenicol-resistance in H. halobium (A2062C, C2452U) (Mankin & Garrett, 1991) and in other organisms (U2504C) (Blanc et al., 1981a,b) . Hence, the Lin binding site appears to overlap closely with the binding site of chloramphenicol. However, while chloramphenicol ef®ciently inhibits peptide bond formation, the situation with the mode of action of oxazolidinones remains less certain. In previous work, seemingly con¯icting results were obtained regarding the effect of oxazolidinones on peptidyl transferase activity, which was measured by puromycin-dependent release of formyl-methionine from fMet-tRNA bound to the mRNA-ribosome complex Burghardt et al., 1998) . In this setting, the extent of the reaction depends on a number of parameters, such as association of ribosomal subunits, interaction of mRNA with the 30 S subunit, tRNAmRNA interaction, etc., and it is not always possible to separate the effect of the drug on any of these interactions from straight inhibition of the catalysis of peptide bond formation. Therefore, in order to overcome this uncertainty, we studied the direct effect of Lin on the activity of ribosomal peptidyl transferase under the so-called``fragment reaction'' conditions (Monro & Marcker, 1967) . In the fragment reaction, formation of the peptide bond between the donor substrate (fMet-tRNA, in our test) and the acceptor substrate (puromycin) can be catalyzed by isolated large ribosomal subunits and does not depend on any of the ribosomal functions related to the activity of the small ribosomal subunit, including mRNA-tRNA interactions. Our results (Figure 4) clearly demonstrate that even when used at a very high concentration, Lin does not notably inhibit the peptidyl transferase elementary reaction. Therefore, it is unlikely that Lin (and probably other oxazolidinones) inhibits protein synthesis by direct interference with the catalytic activity of the peptidyl transferase center.
In addition to peptidyl transferase inhibitors, several other antibiotics, such as macrolides and streptogramins B, that do not directly inhibit activity of peptidyl transferase but rather hinder growth of the nascent peptide chain, also interact with rRNA in the central loop of domain V (Moazed & Noller, 1987; Xiong et al., 1999; Hansen et al., 1999; Porse & Garrett, 1999; Chang et al., 1969) . Most mutations conferring resistance to macrolides and streptogramin B-type antibiotics, as well as footprints produced by these drugs on 23 S rRNA, are restricted to the``left half'' of the central loop of domain V (for a review, see Weisblum, 1995; and see Porse & Garrett, 1999) . In contrast, the Lin r mutations described here are clustered in the right half of the central loop (Figure 3 ) and, thus, practically do not overlap with the sites that are involved in interaction with macrolides and streptogramin B. In addition, mutational analysis and RNA footprinting revealed interaction of macrolides and streptogramins B with the loop of hairpin 35 in domain II (Moazed & Noller, 1987; Xiong et al., 1999; Hansen et al., 1999) , while no interactions of Lin with the loop of the hairpin 35 have been revealed so far. Therefore, the structure of the binding site (and for that reason, probably the mechanism of action) of Lin and other oxazolidinones is likely to be different from that of macrolides and streptogramin B.
Lin has been shown to inhibit incorporation of fMet-tRNA into the translation initiation complex (Swaney et al., 1998a) . From the occurrence of Lin r mutations in 23 S rRNA, one can infer that this inhibition may result from the drug hindering the tRNA interaction with the large ribosomal subunit. At the same time, it is unlikely that Lin prevents positioning of the tRNA 3
H end in the P-site, since no inhibition of the fragment reaction was observed. During translation initiation, the initial orientation of fMet-tRNA in the tRNA/ribosome/ mRNA pre-initiation complex is apparently different from that of the tRNA in the P-site; the tRNA 3 H end has to be``shifted'' or``adjusted'' into the P-site prior to the formation of the ®rst peptide bond (La Teana et al., 1996) . Combining these observations, we propose that oxazolidinones interfere with the initial interaction of fMet-tRNA with the 50 S subunit during formation of the preinitiation complex. Since interaction with the large ribosomal subunit is extremely important for tRNA binding and positioning during translation initiation (Swaney et al., 1998a) , such interference would explain the effect of the drug on tRNA incorporation into the 70 S initiation complex and on general inhibition of translation initiation, which is currently presumed to be the step of protein synthesis where oxazolidinones exert their effects (Eustice et al., 1988; Swaney et al., 1998a; Burghardt et al., 1998) .
Multiple resistance mutations
Different mutations in rRNA can confer resistance to the same antibiotic. For example, mutations at positions 2032, 2057, 2062, 2451, 2452, 2503, 2504 (E. coli numeration) confer resistance to chloramphenicol (for references see Douthwaite, 1992) . Similarly, multiple mutations render halophilic archaea resistant to anisomycin (Hummel & Bo È ck, 1987a; A.S.M., unpublished results) . A similar trend is observed with Lin r mutations described here: seven mutations at six rRNA positions were shown here to confer Lin-resistance in H. halobium. The high number of rRNA positions whose alterations result in drug-resistance may be explained in two different ways. First, the drug may interact directly with a number of rRNA positions. Disruption of any of the multiple contacts of the drug with rRNA would decrease, to a different extent, the stability of the ribosome-antibiotic complex, resulting in the various levels of resistance. An alternative model implies allosteric effects of mutations on the conformation of rRNA within the drug binding site. Speci®c mutations may induce certain changes in rRNA conformation that would reduce drug af®nity. However, chemical probing of rRNA structure in ribosomes of three of the isolated mutants, C2452U, U2500C, and U2504C, did not show any alterations in accessibility of nucleotides in domain V to chemical modi®cation compared to the wild-type ribosome (data not shown). Importantly, all the Lin r mutations described here are located within one of the most functionally critical elements of rRNA. It seems unlikely therefore that signi®cant alterations in RNA conformation in this region would be easily tolerated by the ribosome. Furthermore, since all the isolated mutations have a relatively small effect on cell doubling time (see Table 1 ), we favor the hypothesis that most of the isolated mutations correspond to the rRNA residues that form direct contacts with the drug.
Conclusions
Seven mutations affecting six 23 S rRNA positions within the central loop of domain V were shown to confer resistance to a novel protein synthesis inhibitor, linezolid, which belongs to the class of oxazolidinone antibiotics. Clustering mutations within this region identify this rRNA segment as a primary binding site of the drug on the prokaryotic ribosome. The location of the drug binding site close to the ribosomal peptidyl transferase center allowed us to propose that the drug inhibits incorporation of fMet-tRNA in the tRNA/ ribosome/mRNA pre-initiation complex. This model is compatible with previously reported inhibition of tRNA incorporation into the pre-initiation complex by oxazolidinones and lack of the drug's effect on the catalysis of peptide bond formation.
Materials and Methods
Isolation of Lin r mutant
H. halobium, strain R1 (Stoeckenius & Kunau, 1968 ) was grown in liquid medium or on agar plates as described (Cline et al., 1989) . For isolation of Lin r mutants, 10 9 cells of H. halobium were plated onto agar medium containing 15 mM Lin. After one week of growth at 37 C, approximately 100 colonies appeared on the plate and 21 were chosen for further analysis. The segment of the 23 S rRNA gene corresponding to domain V of 23 S rRNA was ampli®ed directly from the colonies using thè`d irect'' primer GGCCCGGTGAACTGTACG (positions 2004-2021 in 23 S rRNA, E. coli numeration) and thè`r everse'' primer GTTCCTCTCGTACTATACG (positions 2649-2667). PCR products were puri®ed using a PCR puri®cation kit (Promega) and sequenced without additional cloning. Primers used for domain V sequencing have been described (Tan et al., 1996) .
Antibiotic sensitivity of the wild-type or mutant cells was determined in liquid cultures or on agar plates as described (Tan et al., 1996) .
Introduction of C2452U mutation into the wild-type H. halobium chromosomal 23 S rRNA gene
The previously constructed vector pHRZH, which contains a complete rRNA operon from H. halobium with two thiostrepton-resistant mutations (A1067G and A1095G) and an anisomycin-resistance mutation (C2452U) in the 23 S rRNA gene (Mankin et al., 1992; Mankin, 1995) , was used to transform wild-type H. halobium using the described procedure (Cline et al., 1989) . Transformants were selected on agar plates containing 1 mg/ml of thiostrepton (Mankin, 1995) . The segment of the 23 S rRNA gene was ampli®ed directly from several thiostrepton-resistant colonies using a pair of primers, CGAGCTAGGGAGTGTGCCTG (corresponding to 23 S rRNA positions 576-595, E. coli numeration) and GTTAGGTCTCGGTGGCGAAC (complementary to positions 1144-1163), and the presence of Ths r mutations was veri®ed by direct sequencing. Clones containing both Ths r mutations, (A1067G and A1095G) were presumed to be authentic transformants as opposed to clones with single Ths r mutations, which could be spontaneous mutants. The 23 S rRNA domain V was ampli®ed from several colonies and a clone containing the C2452U mutation was found (one of the clones with two Ths r mutations but without C2452U mutation was used as a control in MIC determination experiments).
The minimal inhibitory concentration of Lin for the transformants was determined in liquid culture as described in (Tan et al., 1996) .
Testing effect of Lin on the peptidyl transferase reaction catalyzed by H. halobium ribosomes Wild-type H. halobium ribosomes isolated as described in (Tan et al., 1996) were heat-activated for ten minutes at 42 C in buffer A (20 mM Tris-HCl (pH 7.8), 3.4 M KCl, 0.1 M MgCl 2 , 5 mM b-mercaptoethanol). The in vitro peptidyl transferase assay was performed in the fragment reaction conditions (Monro & Marcker, 1967) with modi®cations as described (Tan et al., 1996) .
